by Mani Padmanabhan, CFO and Co Founder at Price Eagle Online The legal and regulatory landscape has been constantly evolving over the last 20 years. Ethical practices are no longer just “good to have” but are now a “must-have” as people have realized that a lack of ethics and integrity not only leads to […]
Read More
by Ken Powell, President, Genesis Business Development The objective of companion diagnostics (CDx) is to maximize that a patient with a particular disease state has the highest probability of responding to a given therapeutic. CDx is now in its second decade of use, and more FDA-approved therapeutics have corresponding CDx labeling. This growing CDx trend […]
Read More
by Chris Slezakowski, Market Strategist HOW DO YOU KNOW WHEN YOUR BUSINESS NEEDS A BOOST? As businesses evolve, they need to convert or acquire new customers. The services or products provided operate in a complex system of multi-channel marketing, social media, supply-and-demand forces, and, above all, competition. Growing your business takes internal time and thought, […]
Read More
by Ken Powell, President, Genesis Business Development OVERVIEW Laboratory diagnostics are essential to the delivery of healthcare. Over 70% of all clinical decisions are based on a diagnostic test result, highlighting the critical nature of this medical care delivery segment. Yet spending on diagnostics accounts for less than 3% of the annual US healthcare spend. […]
Read More
by Michael Smith, Principal and Founder at MKS Insights You don’t have to be an industry expert or insider to notice that smartphones are getting harder and harder to justify replacing. Outside of the glass shattering or dropping it in the pool, you would need to have a high disposable income to rationalize spending money […]
Read More
by Ken Wahl, VP Business Development, Data Insights, Guidepoint Nevro Corp. (NYSE: NVRO) is a key player in the spinal cord stimulation (SCS) market. Since FDA approval of the Senza system in 2015, Nevro has taken ~15% market share from well-established market leaders Abbott/St. Jude, Medtronic and Boston Scientific. The U.S. SCS market was an […]
Read More
by Kenny Dolgin, Data Insights, Guidepoint Edwards Lifesciences Corp. (NYSE: EW) is a leader in the approximately $3 billion transcatheter heart valve (THV) market, having launched their first SAPIEN valve in the U.S. in 2011 and now having released their third generation valve. From 2013 to 2017, Edwards’ stock price delivered a 5-year CAGR of […]
Read More
by Charles Moore, President, Premier Products On October 14, 2015 Walmart shocked Wall Street with its worst one-day plunge in 27 years. The shares of the corporate giant dropped 10 percent for a loss of $21.5 billion in market capitalization. Since February, Walmart’s stock performance has plummeted 29 percent. Walmart’s senior management team has declared […]
Read More
by Charles Moore, President, Premier Products In 1997, U.S. sales of organic food and beverages totaled less than $4 billion, according to the Organic Trade Association. Fast forward to 2014, and the OTA reports organic sales surpassed $35 billion, with demand projected to grow to over $100 billion by 2025. While U.S. growth in total […]
Read More
By Michael P. Fischetti, Executive Director, National Contract Management Association Government contracting is as old as government itself. Two key factors: 1) reduced budgets and 2) more complex contracts, have forced government to learn more about supply chain learning. First, as budgets and the role of government (particularly Federal) in business declines, the impact […]
Read More纽约 | 波士顿 | 旧金山 | 伦敦 | 杜塞尔多夫 | 新加坡 | 上海 | 香港 | 首尔 | 东京
